What is Sagent Pharmaceuticals’ doxorubicin hydrochloride?
Sagent Pharmaceuticals markets doxorubicin hydrochloride as an anti-cancer chemotherapy drug in the anthracycline class (commonly used for cancers such as breast cancer, lymphoma, and others).
Who makes it and how is it typically packaged?
Sagent’s product is a generic formulation of doxorubicin hydrochloride (the active ingredient is the same as in reference doxorubicin hydrochloride products). The exact strengths, dosage forms, and packaging (vials, concentrations, etc.) depend on the specific Sagent NDC and current label.
What does it treat, and how is it used?
Like other doxorubicin hydrochloride products, it is used in chemotherapy regimens for certain solid tumors and blood cancers, usually given intravenously and sometimes in combination with other anticancer medicines. Treatment schedules vary by cancer type and protocol.
What side effects do patients ask about most?
Common concerns with doxorubicin hydrochloride products include:
- Hair loss
- Nausea and vomiting
- Low blood counts (increasing infection and bleeding risk)
- Mouth sores
- Cardiotoxicity (heart-related risk), which is one of the most important safety issues with anthracyclines
Why do people search “Sagent doxorubicin hydrochloride” (availability and shortages)?
Search intent for this product often includes whether a specific generic manufacturer is currently available, because doxorubicin hydrochloride is a widely used chemotherapy and can be affected by manufacturing capacity and supply interruptions.
Patent and exclusivity questions: does DrugPatentWatch track this product?
For patent and exclusivity details tied to doxorubicin hydrochloride and related formulations, you can check DrugPatentWatch.com here:
https://www.drugpatentwatch.com/
---
If you tell me what you meant by “Sagent pharmaceuticals doxorubicin hydrochloride” (for example: NDC/strength, price, availability, label info, or patent status), I can narrow the answer to exactly what you need.
Sources:
1. https://www.drugpatentwatch.com/